3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide

C122H124F21N47O14S8 — CID 158389410

IUPAC3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide
SMILESNCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCc1ccc(-c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2-c2nn[nH]n2)cc1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3[nH]ccc3c2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnn3ccccc23)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2snc3ncccc23)c1-c1nn[nH]n1
InChIInChI=1S/C23H33F3N6O2S.C22H31F3N6O2S.C16H16F3N9O2S.C16H11F3N6O2S.C16H15F3N6O2S.C15H10F3N7O2S.C14H8F3N7O2S2/c24-23(25,26)19-10-9-18(20(21(19)35(28,33)34)22-29-31-32-30-22)17-7-5-16(6-8-17)13-15-3-1-14(2-4-15)11-12-27;23-22(24,25)18-10-9-17(19(20(18)34(27,32)33)21-28-30-31-29-21)16-7-5-14(6-8-16)11-13-1-3-15(12-26)4-2-13;17-16(18,19)11-2-1-10(12(13(11)31(20,29)30)14-24-26-27-25-14)9-7-22-15(23-8-9)28-5-3-21-4-6-28;17-16(18,19)11-3-2-10(8-1-4-12-9(7-8)5-6-21-12)13(14(11)28(20,26)27)15-22-24-25-23-15;17-16(18,19)12-6-5-11(10-3-1-9(2-4-10)7-8-20)13(14(12)28(21,26)27)15-22-24-25-23-15;16-15(17,18)10-5-4-8(9-7-20-25-6-2-1-3-11(9)25)12(13(10)28(19,26)27)14-21-23-24-22-14;15-14(16,17)8-4-3-6(10-7-2-1-5-19-12(7)22-27-10)9(11(8)28(18,25)26)13-20-23-24-21-13/h9-10,14-17H,1-8,11-13,27H2,(H2,28,33,34)(H,29,30,31,32);9-10,13-16H,1-8,11-12,26H2,(H2,27,32,33)(H,28,29,30,31);1-2,7-8,21H,3-6H2,(H2,20,29,30)(H,24,25,26,27);1-7,21H,(H2,20,26,27)(H,22,23,24,25);1-6H,7-8,20H2,(H2,21,26,27)(H,22,23,24,25);1-7H,(H2,19,26,27)(H,21,22,23,24);1-5H,(H2,18,25,26)(H,20,21,23,24)
InChIKeyGWTNXCUUPLWEOC-UHFFFAOYSA-N
MW3128.14 g/mol
LogP17.15
Rot. Bonds31

About 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide

3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide (PubChem CID 158389410) has the molecular formula C122H124F21N47O14S8 and a molecular weight of 3128.14 g/mol. Its IUPAC name is 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide.

Molecular Properties

Compound Name3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide
PubChem CID158389410
Molecular FormulaC122H124F21N47O14S8
Molecular Weight3128.14 g/mol
Exact Mass3125.79
IUPAC Name3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide
SMILESNCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCc1ccc(-c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2-c2nn[nH]n2)cc1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3[nH]ccc3c2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnn3ccccc23)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2snc3ncccc23)c1-c1nn[nH]n1
InChIInChI=1S/C23H33F3N6O2S.C22H31F3N6O2S.C16H16F3N9O2S.C16H11F3N6O2S.C16H15F3N6O2S.C15H10F3N7O2S.C14H8F3N7O2S2/c24-23(25,26)19-10-9-18(20(21(19)35(28,33)34)22-29-31-32-30-22)17-7-5-16(6-8-17)13-15-3-1-14(2-4-15)11-12-27;23-22(24,25)18-10-9-17(19(20(18)34(27,32)33)21-28-30-31-29-21)16-7-5-14(6-8-16)11-13-1-3-15(12-26)4-2-13;17-16(18,19)11-2-1-10(12(13(11)31(20,29)30)14-24-26-27-25-14)9-7-22-15(23-8-9)28-5-3-21-4-6-28;17-16(18,19)11-3-2-10(8-1-4-12-9(7-8)5-6-21-12)13(14(11)28(20,26)27)15-22-24-25-23-15;17-16(18,19)12-6-5-11(10-3-1-9(2-4-10)7-8-20)13(14(12)28(21,26)27)15-22-24-25-23-15;16-15(17,18)10-5-4-8(9-7-20-25-6-2-1-3-11(9)25)12(13(10)28(19,26)27)14-21-23-24-22-14;15-14(16,17)8-4-3-6(10-7-2-1-5-19-12(7)22-27-10)9(11(8)28(18,25)26)13-20-23-24-21-13/h9-10,14-17H,1-8,11-13,27H2,(H2,28,33,34)(H,29,30,31,32);9-10,13-16H,1-8,11-12,26H2,(H2,27,32,33)(H,28,29,30,31);1-2,7-8,21H,3-6H2,(H2,20,29,30)(H,24,25,26,27);1-7,21H,(H2,20,26,27)(H,22,23,24,25);1-6H,7-8,20H2,(H2,21,26,27)(H,22,23,24,25);1-7H,(H2,19,26,27)(H,21,22,23,24);1-5H,(H2,18,25,26)(H,20,21,23,24)
InChIKeyGWTNXCUUPLWEOC-UHFFFAOYSA-N
XLogP17.15
TPSA980.32 Ų
H-Bond Donors19
H-Bond Acceptors47
Rotatable Bonds31
Heavy Atoms212
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003128.14
LogP ≤ 517.15
H-Bond Donors ≤ 519
H-Bond Acceptors ≤ 1047

Analyze 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide?
The IUPAC name of 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide (CID 158389410) is 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide.
What is the SMILES notation for 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide?
The canonical SMILES for 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide is NCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCC1CCC(CC2CCC(c3ccc(C(F)(F)F)c(S(N)(=O)=O)c3-c3nn[nH]n3)CC2)CC1.NCCc1ccc(-c2ccc(C(F)(F)F)c(S(N)(=O)=O)c2-c2nn[nH]n2)cc1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc3[nH]ccc3c2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnc(N3CCNCC3)nc2)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2cnn3ccccc23)c1-c1nn[nH]n1.NS(=O)(=O)c1c(C(F)(F)F)ccc(-c2snc3ncccc23)c1-c1nn[nH]n1.
What is the InChIKey of 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide?
The InChIKey is GWTNXCUUPLWEOC-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H33F3N6O2S.C22H31F3N6O2S.C16H16F3N9O2S.C16H11F3N6O2S.C16H15F3N6O2S.C15H10F3N7O2S.C14H8F3N7O2S2/c24-23(25,26)19-10-9-18(20(21(19)35(28,33)34)22-29-31-32-30-22)17-7-5-16(6-8-17)13-15-3-1-14(2-4-15)11-12-27;23-22(24,25)18-10-9-17(19(20(18)34(27,32)33)21-28-30-31-29-21)16-7-5-14(6-8-16)11-13-1-3-15(12-26)4-2-13;17-16(18,19)11-2-1-10(12(13(11)31(20,29)30)14-24-26-27-25-14)9-7-22-15(23-8-9)28-5-3-21-4-6-28;17-16(18,19)11-3-2-10(8-1-4-12-9(7-8)5-6-21-12)13(14(11)28(20,26)27)15-22-24-25-23-15;17-16(18,19)12-6-5-11(10-3-1-9(2-4-10)7-8-20)13(14(12)28(21,26)27)15-22-24-25-23-15;16-15(17,18)10-5-4-8(9-7-20-25-6-2-1-3-11(9)25)12(13(10)28(19,26)27)14-21-23-24-22-14;15-14(16,17)8-4-3-6(10-7-2-1-5-19-12(7)22-27-10)9(11(8)28(18,25)26)13-20-23-24-21-13/h9-10,14-17H,1-8,11-13,27H2,(H2,28,33,34)(H,29,30,31,32);9-10,13-16H,1-8,11-12,26H2,(H2,27,32,33)(H,28,29,30,31);1-2,7-8,21H,3-6H2,(H2,20,29,30)(H,24,25,26,27);1-7,21H,(H2,20,26,27)(H,22,23,24,25);1-6H,7-8,20H2,(H2,21,26,27)(H,22,23,24,25);1-7H,(H2,19,26,27)(H,21,22,23,24);1-5H,(H2,18,25,26)(H,20,21,23,24).
What are the key properties of 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide?
3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide has a molecular weight of 3128.14 g/mol, XLogP of 17.15, 31 rotatable bonds, 19 hydrogen bond donors, and 47 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[4-[[4-(2-aminoethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-(2-aminoethyl)phenyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-[4-[[4-(aminomethyl)cyclohexyl]methyl]cyclohexyl]-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(1H-indol-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-(2-piperazin-1-ylpyrimidin-5-yl)-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;3-pyrazolo[1,5-a]pyridin-3-yl-2-(2H-tetrazol-5-yl)-6-(trifluoromethyl)benzenesulfonamide;2-(2H-tetrazol-5-yl)-3-([1,2]thiazolo[3,4-b]pyridin-3-yl)-6-(trifluoromethyl)benzenesulfonamide is sourced from PubChem (CID 158389410), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).